News | September 05, 2025
FDA completes inspection at Biocon Biologics' facility in Bengaluru
The U.S. FDA issued a Form 483 with five observations
The U.S. FDA issued a Form 483 with five observations
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
Subscribe To Our Newsletter & Stay Updated
